Understanding and targeting protein synthesis in leukemia stem cells

The University of Texas Southwestern Medical Center will receive $573,999 under a Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program to support research understanding and targeting protein synthesis in leukemia stem cells. The three-year award beginning August 15, 2022 will fund investigation into medical solutions for leukemia at the cellular level through basic, applied, and advanced biomedical research. As the prime awardee, Southwestern Medical School will conduct the research with its parent organization, the University of Texas System, providing administrative and other support services. The grant aims to advance the Military Medical Research and Development program's goals of transforming military and public health through innovative medical research solutions applicable to battlefield care and beyond.